Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Seasonal effects on cortisol secretion in normal aging, mild cognitive impairment and Alzheimer's disease.

Arsenault-Lapierre G, Chertkow H, Lupien S.

Neurobiol Aging. 2010 Jun;31(6):1051-4. doi: 10.1016/j.neurobiolaging.2008.07.011. Epub 2008 Aug 15.

PMID:
18703254
2.
3.

Salivary cortisol day profiles in elderly with mild cognitive impairment.

Wolf OT, Convit A, Thorn E, de Leon MJ.

Psychoneuroendocrinology. 2002 Oct;27(7):777-89.

PMID:
12183214
4.

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.

Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.

Neurosci Lett. 2005 Aug 12-19;384(1-2):23-8.

PMID:
15905028
5.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
6.

CSF cortisol in Alzheimer's disease and mild cognitive impairment.

Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner U, Jessen F.

Neurobiol Aging. 2009 Mar;30(3):498-500. Epub 2007 Aug 22.

PMID:
17716786
7.

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ.

Ann Neurol. 2002 Feb;51(2):145-55.

PMID:
11835370
8.
9.

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.

Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH.

J Comp Neurol. 2000 Nov 6;427(1):19-30.

PMID:
11042589
10.

Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.

Liddell BJ, Paul RH, Arns M, Gordon N, Kukla M, Rowe D, Cooper N, Moyle J, Williams LM.

J Integr Neurosci. 2007 Mar;6(1):141-74.

PMID:
17472227
11.

Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.

Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, Farías G, Fuentes P.

Neurobiol Aging. 2006 Feb;27(2):237-44. Epub 2005 Apr 7.

PMID:
16399209
12.

Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.

Egerházi A, Berecz R, Bartók E, Degrell I.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):746-51. Epub 2007 Jan 16.

PMID:
17289240
13.

Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.

Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I.

Psychol Med. 2007 May;37(5):747-55. Epub 2006 Dec 13.

PMID:
17164030
14.

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.

Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH.

J Comp Neurol. 2002 Feb 4;443(2):136-53.

PMID:
11793352
15.

CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.

Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.

Acta Neurol Scand. 2005 Mar;111(3):172-9.

PMID:
15691286
16.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC.

Brain. 2007 Nov;130(Pt 11):2837-44. Epub 2007 Oct 10.

PMID:
17928318
17.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
18.

[Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].

Barth S, Schönknecht P, Pantel J, Schröder J.

Fortschr Neurol Psychiatr. 2005 Oct;73(10):568-76. German.

PMID:
16217697
19.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
20.

Memory profiling with paired associate learning in Alzheimer's disease, mild cognitive impairment, and healthy aging.

Pike KE, Rowe CC, Moss SA, Savage G.

Neuropsychology. 2008 Nov;22(6):718-28. doi: 10.1037/a0013050.

PMID:
18999345

Supplemental Content

Support Center